TrialNature medicine2024

Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.

Ying Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.